8096 J . Org. Chem., Vol. 64, No. 22, 1999
Wang and J ust
ratio of 6:1 as established by 31P NMR. 31P NMR (202.3 MHz,
CDCl3): δ 120.53 (85.3%), 120.72 (14.7%). The following NMR
spectra were assigned for the major isomer. 1H NMR (500
MHz, CDCl3): δ 9.20 (s, br, 1H), 7.42 (s, 1H), 7.57-7.17 (m,
4H), 6.42 (s, 1H), 6.34 (dd, J ) 8.8, 5.0 Hz, 1H), 4.82 (m, 1H),
4.47 (m, 1H), 3.94 (m, 1H), 3.76, 3.66 (m, 2H), 3.40-3.24 (m,
2H), 2.91 (m, 2H), 2.41, 2.01 (m, 2H), 1.89 (s, 3H), 0.88 (s, 9H),
0.066 (ss, 6H). 13C NMR (67.9 MHz, CDCl3): δ 163.66, 150.41,
138.11, 137.87, 135.14, 133.60, 129.67, 122.78, 121.86, 120.75,
116.13, 111.18, 110.51 (d, J ) 10.8 Hz), 104.41, 86.41 (d, J )
4.1 Hz), 84.81, 75.49 (d, J ) 12.9 Hz), 70.71 (d, J ) 8.2 Hz),
63.15, 39.82, 30.88 (d, J ) 5.7 Hz), 25.96, 25.66, 18.36, 12.55,
-5.30, -5.41. MS (FAB, NBA): 557 (M - HCN, 44.5).
In d olyl-oxa za p h osp h or in e (7Sc). By the same procedure
as described for 7b, 42 mg (58%) of 7Sc was obtained from 5c
(30 mg, 0.11 mmol). Two diastereoisomers of 7Sc were
obtained in a ratio of 6.8:1 as established by 31P NMR. 31P
NMR (202.3 MHz, CDCl3): δ 120.76 (12.8%), 120.68 (87.2%).
1H NMR (500 MHz, CDCl3): δ 8.16 (s, br, 1H), 7.39 (s, 1H),
7.54-7.17 (m, 4H), 6.35 (m, 2H), 4.74 (m, 1H), 4.46 (m, 1H),
4.10 (m, 2H), 3.89, 3.47 (m, 3H), 3.11 (m, 1H), 2.4, 1.9 (m, 2H),
2.17 (s, 3H), 1.86 (s, 3H), 1.24 (m, 6H), 0.87 (s, 9H), 0.035 (ss,
6H).
24:1 as established by 31P NMR. 31P NMR (202.3 MHz,
CDCl3): δ 66.31 ppm (96%), 65.73 (4%). H NMR (500 MHz,
1
CDCl3): δ 9.16 (s, br, 1H), 9.13 (s, br, 1H), 8.60 (s, br, 1H),
7.63-7.05 (m, 16H), 6.33 (s, 1H), 6.27 (m, 1H), 6.17 (dd, J )
9.0, 5.0 Hz, 1H), 4.91 (m, 2H), 4.30 (m, 1H), 4.10 (m, 1H), 3.88
(m, 1H), 3.79 (m, 2H), 3.54, 3.45 (m, 2H), 3.19 (m, 2H), 2.65
(m, 2H), 2.28 (m, 2H), 2.01 (m, 1H), 1.89 (s, 3H), 1.86 (s, 3H),
1.87 (m, 1H), 1.06 (s, 9H), 0.88 (s, 9H), 0.068 (ss, 6H). 13C NMR
(67.9 MHz, CDCl3): δ 163.82, 163.71, 150.35, 150.27, 136.33,
136.10, 135.79, 134.85, 132.96, 132.81, 131.61, 130.30, 128.33,
128.13, 128.06, 122.20, 120.24, 115.85, 111.36 (d, J ) 7.7 Hz),
110.94, 102.61, 86.32, 85.49 (d, J ) 6.2 Hz), 85.13 (d, J ) 8.2
Hz), 84.60, 80.75 (d, J ) 4.6 Hz), 77.29, 74.23 (d, J ) 5.1 Hz),
73.06, 67.86 (d, J ) 6.7 Hz), 63.16, 39.92, 38.92 (d, J ) 4.1
Hz), 33.57 (d, J ) 4.6 Hz), 31.00, 26.90, 25.96, 23.65 (d, J )
4.6 Hz), 19.06, 18.34, 12.58 (d, J ) 4.6 Hz), -5.33, -5.41. MS
(FAB, NBA): 1097 (MH+, 11.1), 759 (5.4), 377 (28.1), 339
(51.7), 182 (100).
P h osp h or oth ioa te Tr iester (9Sd ). By the same procedure
as described for 9b, 18 mg (70%) of 9Sd was obtained from
7Sd (15 mg, 0.022 mmol). Triester 9Sd was directly used in
the next step to test the removal of silyloxyl chiral auxiliary
in the presence of TBAF. 31P NMR (109.4 MHz, CDCl3): δ
69.10 ppm.
In d olyl-oxa za p h osp h or in e (7Sd ). By the same procedure
as described for 7b, 15 mg (22%) of white solid 7Sd was
obtained from 5d (60 mg, 0.20 mmol), mp 70-71 °C. Two
diastereoisomers of 7Sd were obtained in a ratio of 14:1 as
Dith ym id in yl P h osp h or oth ioa te (Sp -10). To a solution
of 9b (60 mg, 0.056 mmol) in methanol (1 mL) was added 20
mL of aqueous ammonia (28%). The solution was stirred at
50 °C for 30 min, neutralized with HCl (6 N), and extracted
with ethyl acetate. The combined extracts were dried over
anhydrous sodium sulfate. The solvent was evaporated, and
the residue was purified by flash chromatography (acetone/
triethylamine 10:1) to give 32 mg (58%) of Sp-10 which existed
as a triethylammonium salt. 31P NMR (202.3 MHz, CD3OD):
established by 31P NMR. 31P NMR (202.3 MHz, CDCl3):
δ
1
121.02 (6.8%), 120.64 (93.2%). H NMR (500 MHz, CDCl3): δ
8.30 (s, br, 1H), 7.38 (d, J ) 1.5 Hz), 7.54-7.13 (m, 4H), 6.36
(m, 2H), 4.75 (m, 1H), 4.42 (m, 1H), 3.87 (m, 2H), 3.80 (m,
1H), 3.72 (m, 1H), 3.16 (m, 3H), 2.29 (m, 1H), 1.89 (m, 1H),
1.85 (d, J ) 1.0 Hz, 3H), 0.90, 0.84 (ss, 18H), 0.097(ss, 12H).
13C NMR (125.7 MHz, CDCl3): δ 163.25, 149.82, 137.78,
137.66, 135.62, 134.98, 129.63, 122.04, 121.28, 120.22, 110.75,
110.20 (d, J ) 10.9 Hz), 103.38, 86.23, 84.47, 75.68 (d, J ) 7.4
Hz), 73.79 (d, J ) 10.0 Hz), 66.08, 62.70, 39.71, 29.52, 28.45
(d, J ) 5.5 Hz), 28.02, 25.71, 18.21 (d, J ) 11.9 Hz), 12.28,
-5.45, -5.56, -5.69. MS (FAB, NBA): 690 (MH+, 2.76), 689
(M+, 6.21).
1
δ 58.98 ppm. H NMR (500 MHz, CDCl3): δ 7.76 (d, J ) 1.0
Hz, 1H), 7.56-7.31 (m, 10H), 7.48 (d, J ) 1.0 Hz, 1H), 6.39
(dd, J ) 9.2, 5.0 Hz, 1H), 6.05 (dd, J ) 8.8, 5.0 Hz, 1H), 4.88
(m, 1H), 4.47 (m, 1H), 3.98 (m, 1H), 3.95 (m, 1H), 3.74, 3.50
(m, 2H), 3.67 (m, 2H), 2.86, 1.10 (q, t, N(CH2CH3)3), 2.28 (m,
1H), 2.00 (m, 3H), 1.83 (d, J ) 1.0 Hz, 3H), 1.76 (d, J ) 1,0
Hz, 3H), 0.98 (s, 9H), 0.80 (s, 9H), 0.009 (ss, 6H). 13C NMR
(125.7 MHz, CD3OD): δ 166.3, 166.2, 152.4, 151.9, 138.0,
137.2, 136.8, 136.8, 134.3, 134.2, 131.1, 131.0, 129.0, 128.9,
112.2, 111.0, 88.0 (d, J ) 9.1 Hz), 87.6 (d, J ) 4.6 Hz), 86.3,
86.1, 77.9 (d, J ) 5.5 Hz), 76.3, 66.4 (d, J ) 6.4 Hz), 64.8, 47.4
(NEt3), 41.3, 40.5 (d, J ) 4.5 Hz), 27.2, 26.4, 19.6, 19.1, 12.6,
12.5, 9.7 (NEt3), -5.22, -5.28. MS (FAB, NBA): m/e 937
(MNa+).
P h osp h or ot h ioa t e Tr iest er (9b ). To a round-bottomed
flask was added 7b (80 mg, 0.137 mmol) and 3′-O-TBDPS-
thymidine (50 mg, 0.104 mmol). The flask was flushed with
argon and sealed with a septum. Dry THF (0.5 mL) was
introduced followed by DBU (40 µL, 0.268 mmol) via a syringe.
This reaction mixture was shaken at room temperature for
10 min and passed though a short silica gel column to remove
DBU, and the column was eluted with CH3CN. The solvent
was evaporated to afford light yellow solid. This solid was
redissolved in dry CH2Cl2 (2 mL), and Beaucage’s reagent (35
mg, 0.175 mmol) was added. After 5 min, evaporation of the
solvent followed by flash chromatography (dichloromethane/
acetone 5:1) afforded 84 mg (74%) of light yellow solid
phosphorothioate triester 9b, mp 113-114 °C. 31P NMR (202.3
MHz, CDCl3): δ 66.55 ppm. 1H NMR (500 MHz, CDCl3): δ
10.21 (s, br, 1H), 9.56 (s, br, 1H), 9.14 (s, br, 1H), 7.62-6.92
(m, 16 H), 6.35 (m, 1H), 6.28 (s, 1H), 6.06 (dd, J ) 9.0, 5.5 Hz,
1H), 4.88 (m, 1H), 4.82 (m, 2H), 4.32 (m, 1H), 4.06 (m, 1H),
3.93 (m, 1H), 3.88 (m, 1H), 3.71 (m, 2H), 3.63 (m, 1H), 3.21
(m, 2H), 2.61 (m, 2H), 2.29, 1.95 (m, 2H), 1.90 (s, 3H), 1.88 (s,
3H), 1.82, 1.40 (m, 2H), 1.06 (s, 9H), 0.88 (s, 9H), 0.063 (ss,
6H). 13C NMR (125.7 MHz, CDCl3): δ 164.13, 164.09, 150.70,
150.35, 135.82, 135.65, 135.54, 134.65, 132.75, 132.51, 131.97,
130.12 (d, J ) 3.6 Hz), 128.32, 127.93, 127.89, 121.45, 119.76,
119.56, 115.63, 111.22 (d, J ) 2.7 Hz), 110.80, 101.26, 85.24
(d, J ) 8.1 Hz), 84.94, 84.76 (d, J ) 9.1 Hz), 84.44, 80.32, 74.02
(d, J ) 4.6 Hz), 72.55, 67.22 (d, J ) 5.5 Hz), 63.02, 39.89, 38.16,
33.18 (d, J ) 6.4 Hz), 26.67, 25.75, 23.45, 18.81, 18.12, 12.41
(d, J ) 7.2 Hz), -5.5, -5.6. HRMS (FAB, NBA/CsI): m/e calcd
for C54H69N6O11Si2PSCs [MCs+] 1229.30755, found 1229.30710.
P h osp h or oth ioa te Tr iester (9Sb). By the same procedure
as described for 9b, 388 mg (68%) of white solid 9Sb was
obtained from the reaction of 7Sb (307 mg, 0.526 mmol) and
3′-O-TBDPS-thymidine (253 mg, 0.526 mmol), mp 116-117
°C. Two diastereoisomers of 9Sb were obtained in a ratio of
P h osp h or oth ioa te (Sp -11). A solution of TBAF (1.0 M in
DMF, 4 mL) containing dimer Sp-10 (20 mg, 0.017 mmol) was
stirred at room temperature for 1 h. The solvent was evapo-
rated under vacuum, and the residue was purified by flash
chromatography (acetone/triethylamine 1:1) to give 15 mg
(95%) of Sp-11, which existed as a tetrabutylammonium salt.
31P NMR (202.3 MHz): δ 58.76 ppm (CD3OD), 55.45 ppm
(D2O). 1H NMR (500 MHz, CD3OD): δ 7.80 (d, J ) 1.0 Hz,
1H), 7.78 (d, J ) 1.5 Hz), 6.29 (dd, J ) 8.0, 6.0 Hz, 1H), 6.22
(dd, J ) 8.0, 6.0 Hz, 1H), 4.98 (m, 1H), 4.45 (m, 1H), 4.12 (m,
1H), 4.09, 3.98 (m, 2H), 3.98 (m, 1H), 3.74 (m, 2H), 3.17, 1.59,
1.35, 0.94 (NBu4+), 2.40 (m, 1H), 2.20 (m, 2H), 2.12 (m, 1H),
1.89 (d, J ) 1.0 Hz, 3H), 1.80 (d, J ) 1.0 Hz, 3H). 13C NMR
(125.7 MHz, CD3OD): δ 166.4, 166.3, 152.4, 152.2, 138.08,
138.06, 112.0, 111.5, 87.6 (d, J ) 5.5 Hz), 87.3 (d, J ) 10.0),
86.1, 86.0, 77.0 (d, J ) 5.5 Hz), 72.8, 66.6 (d, J ) 5.4 Hz), 62.7,
59.39 (t, NBu4+), 40.7, 40.0 (d, J ) 4.5 Hz), 24.69 (NBu4+),
20.61 (NBu4+), 13.85 (NBu4+), 12.6, 12.3. HRMS (FAB): m/e
calcd for C20H27N4O11PSNa [MNa+] 585.10323, found 585.10340.
Dith ym id in yl p h osp h or oth ioa te (Rp -10) was obtained
from 9Sb in 80% yield as described for Sp-10. 31P NMR (202.3
MHz, CD3OD): δ 59.07 ppm. The minor isomer could not be
1
identified from its 31P NMR. H NMR (500 MHz, CD3OD): δ
7.69 (d, J ) 1.0 Hz, 1H), 7.49-7.24 (m, 10H), 7.44 (d, J ) 1.0
Hz, 1H), 6.32 (dd, J ) 9.0, 5.5 Hz, 1H), 6.02 (dd, J ) 8.5, 5.5
Hz, 1H), 4.83 (m, 1H), 4.40 (m, 1H), 4.05 (m, 1H), 3.92 (m,
1H), 3.72 (m, 2H), 3.45 (m, 1H), 2.84, 1.04 (q, t, NEt3), 2.07
(m, 2H), 1.92 (m, 1H), 1.80 (m, 1H), 1.76 (br), 1.71 (d, J ) 1.0